A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
| Autor: | Vijay K. Shukla, D C Doval, B.S. Awasthy, J Fuloria, S Gupta, Saroj Gupta, J S Sekhon |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2004 |
| Předmět: |
Adult
Male Cancer Research medicine.medical_specialty medicine.medical_treatment Phases of clinical research cisplatin Neutropenia Gastroenterology Deoxycytidine Clinical Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Survival rate Aged Neoplasm Staging Chemotherapy Bladder cancer Performance status business.industry gall bladder cancer gemcitabine Middle Aged medicine.disease Survival Analysis Gemcitabine Surgery Treatment Outcome Oncology Disease Progression Female Gallbladder Neoplasms business Progressive disease medicine.drug |
| Zdroj: | British Journal of Cancer |
| ISSN: | 1532-1827 0007-0920 |
| Popis: | The primary objective of this study was to determine the response rates of the gemcitabine and cisplatin combination in unresectable gall bladder cancer patients. The secondary objectives were to evaluate the toxicity, time to progressive disease, and overall survival. Chemonaive patients with histologically proven, unresectable bidimensionally measurable gall bladder cancer were enrolled into this study. All patients were required to have a Zubrod's performance status |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|